Information Provided By: 
Fly News Breaks for June 10, 2016
RARE
Jun 10, 2016 | 07:53 EDT
Leerink analyst Joseph Schwartz raised his price target for Ultragenyx to $85 from $80 as he is "more optimistic" about its UX003/rhGUS for MPS7 disorder ahead of pivotal data in mid-2016. While rhGUS' market opportunity is on the low end, Schwartz believes it should be durable and positive rhGUS data would be a significant indicator that the company is on the verge of becoming a commercial organization. Leerink has an Outperform rating on the shares.
News For RARE From the Last 2 Days
There are no results for your query RARE
